SCHEMBL6959876

SCHEMBL6959876

CCN1c2ncc(C#Cc3ccccc3[N+](=O)[O-])cc2C(=O)N(C)c2ccc(Cl)nc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
CYP1A2 P05177 1/20 0.34
NR1H2 P55055 1/20 0.32
NR1H3 Q13133 1/20 0.32
ACHE P22303 1/20 0.32
HSD11B1 P28845 1/20 0.31
PDE5A O76074 1/20 0.30
GABRA1 P14867 1/20 0.30
GABRG2 P18507 1/20 0.30
GABRB3 P28472 1/20 0.30
GABRA5 P31644 1/20 0.30
GABRA3 P34903 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30
MAPK1 P28482 1/20 0.30
KMT2A Q03164 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6960056 0.86 CYP3A4 (0.41) CYP3A4CYP2C9CYP2C19CYP1A2GRM4
SCHEMBL8691152 0.81 CYP3A4 (0.40) CYP3A4CYP2C9CYP2C19CYP1A2MEN1
SCHEMBL6958757 0.79 CYP3A4 (0.38) CYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL6954103 0.79 CYP3A4 (0.40) CYP3A4CYP2C9CYP2C19CYP1A2GABRA1
SCHEMBL6960656 0.77 CYP3A4 (0.37) CYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL6960522 0.75 PTGS2 (0.38) CYP3A4CYP2C9CYP2C19CYP1A2NR1H2
SCHEMBL6960520 0.75 PTGS2 (0.38) CYP3A4CYP2C9CYP2C19CYP1A2NR1H2
SCHEMBL6961473 0.75 SMN1; SMN2 (0.44) NR1H2NR1H3MEN1ALDH1A1MAPT
SCHEMBL6961468 0.75 SMN1; SMN2 (0.44) NR1H2NR1H3MEN1ALDH1A1MAPT
SCHEMBL6965878 0.74 CYP2C9 (0.42) CYP3A4CYP2C9CYP2C19CYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0767172-B1 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 2003-03-26 EP disclosed
US-5705499-A VIRICIDES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1998-01-06 US disclosed
EP-0767172-A1 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1997-04-09 EP disclosed